SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000849146-18-000092
Filing Date
2018-11-01
Accepted
2018-11-01 16:08:03
Documents
45
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q lfvn_093018x10q.htm 10-Q 601563
2 EXHIBIT 31.1 lfvn_093018xex311.htm EX-31.1 11542
3 EXHIBIT 31.2 lfvn_093018xex312.htm EX-31.2 11531
4 EXHIBIT 32.1 lfvn_093018xex321.htm EX-32.1 5674
5 EXHIBIT 32.2 lfvn_093018xex322.htm EX-32.2 5663
  Complete submission text file 0000849146-18-000092.txt   2754679

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT lfvn-20180930.xml EX-101.INS 342503
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lfvn-20180930.xsd EX-101.SCH 23945
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lfvn-20180930_cal.xml EX-101.CAL 53430
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lfvn-20180930_def.xml EX-101.DEF 81878
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lfvn-20180930_lab.xml EX-101.LAB 364872
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lfvn-20180930_pre.xml EX-101.PRE 197854
Mailing Address 9785 S. MONROE STREET SUITE 300 SANDY UT 84070
Business Address 9785 S. MONROE STREET SUITE 300 SANDY UT 84070 801-432-9000
Lifevantage Corp (Filer) CIK: 0000849146 (see all company filings)

IRS No.: 841097796 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-35647 | Film No.: 181153801
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1